Efficient radiosynthesis and preclinical evaluation of [18F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging

被引:7
|
作者
Singleton, Thomas A. [1 ]
Bdair, Hussein [1 ,4 ]
Bailey, Justin J. [2 ]
Choi, Sangho [2 ]
Aliaga, Arturo [3 ]
Rosa-Neto, Pedro [1 ,3 ,4 ]
Schirrmacher, Ralf [2 ]
Bernard-Gauthier, Vadim [2 ]
Kostikov, Alexey [1 ,4 ]
机构
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Univ Alberta, Dept Oncol, Div Oncol Imaging, Edmonton, AB, Canada
[3] Douglas Mental Hlth Univ Inst, McGill Ctr Studies Aging, Translat Neuroimaging Lab, Montreal, PQ, Canada
[4] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
关键词
F-18]FOMPyD; brain imaging; colony stimulating factor receptor (CSF-1R); copper-mediated F-18-fluorination; fluorine-18; GW2580; PET; positron emission tomography; tropomyosin receptor kinase (Trk); INHIBITOR;
D O I
10.1002/jlcr.3827
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Herein we report an efficient radiolabeling of a F-18-fluorinated derivative of dual inhibitor GW2580, with its subsequent evaluation as a positron emission tomography (PET) tracer candidate for imaging of two neuroreceptor targets implicated in the pathophysiology of neurodegeneration: tropomyosin receptor kinases (TrkB/C) and colony stimulating factor receptor (CSF-1R). [F-18]FOMPyD was synthesized from a boronic acid pinacolate precursor via copper-mediated F-18-fluorination concerted with thermal deprotection of the four Boc groups on a diaminopyrimidine moiety in an 8.7 +/- 2.8% radiochemical yield, a radiochemical purity >99%, and an effective molar activity of 187 +/- 93 GBq/mu mol. [F-18]FOMPyD showed moderate brain permeability in wild-type rats (SUVmax = 0.75) and a slow washout rate. The brain uptake was partially reduced (Delta AUC(40-90) = 11.6%) by administration of the nonradioactive FOMPyD (up to 30 mu g/kg). In autoradiography, [F-18]FOMPyD exhibits ubiquitous distribution in rat and human brain tissues with relatively high nonspecific binding revealed by self-blocking experiment. The binding was blocked by TrkB/C inhibitors, but not with a CSF-1R inhibitor, suggesting selective binding to the former receptor. Although an unfavorable pharmacokinetic profile will likely preclude application of [F-18]FOMPyD as a PET tracer for brain imaging, the concomitant one-pot copper-mediated F-18-fluorination/Boc-deprotection is a practical technique for the automated radiosynthesis of acid-sensitive PET tracers.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [21] Positron emission tomography imaging of cell death with [18F]FPDuramycin
    Shaobo Yao
    Kongzhen Hu
    Ganghua Tang
    Xiang Liang
    Kan Du
    Dahong Nie
    Shende Jiang
    Linquan Zang
    Apoptosis, 2014, 19 : 841 - 850
  • [22] [18F]-FDopa positron emission tomography imaging in corticobasal syndrome
    Anaïs El Ouartassi
    Caroline Giordana
    Aurélie Schiazza
    David Chardin
    Jacques Darcourt
    Brain Imaging and Behavior, 2023, 17 : 619 - 627
  • [23] Positron emission tomography imaging of cell death with [18F]FPDuramycin
    Yao, Shaobo
    Hu, Kongzhen
    Tang, Ganghua
    Liang, Xiang
    Du, Kan
    Nie, Dahong
    Jiang, Shende
    Zang, Linquan
    APOPTOSIS, 2014, 19 (05) : 841 - 850
  • [24] Radiosynthesis of 10-(2-[18F]fluoroethoxy)-20(S)-camptothecin as a potential positron emission tomography tracer for the imaging of topoisomerase I in cancers
    Liu, Zhen-feng
    Wang, Guo-lin
    Dong, Meng-jie
    Jin, Jian-wen
    Li, Jia-jun
    Zhang, Qian
    Zhao, Kui
    Yang, Shu-ye
    Lin, Xiang-tong
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2014, 299 (03) : 1509 - 1515
  • [25] Synthesis and evaluation of 18F -labeled CJ-042794 for imaging prostanoid EP4 receptor expression in cancer with positron emission tomography
    Zhang, Zhengxing
    Lau, Joseph
    Kuo, Hsiou-Ting
    Zhang, Chengcheng
    Colpo, Nadine
    Benard, Francois
    Lin, Kuo-Shyan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (10) : 2094 - 2098
  • [26] Labeling Strategies of Peptides with 18F for Positron Emission Tomography
    Olberg, D. E.
    Hjelstuen, O. K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (16) : 1669 - 1679
  • [27] Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [18F]MeTz-PEG2-RM26 for positron emission tomography
    Panagiotis Kanellopoulos
    Fanny Lundmark
    Ayman Abouzayed
    Lorenzo Jacopo Ilic Balestri
    Esther Olaniran Håkansson
    Karim Obeid
    Luke R. Odell
    Vladimir Tolmachev
    Ulrika Rosenström
    Jonas Eriksson
    Anna Orlova
    EJNMMI Radiopharmacy and Chemistry, 10 (1)
  • [28] Purification of [18F]-fluoro-L-thymidine ([18F]-FLT) for positron emission tomography imaging
    Bourgeois, Mickael
    Mougin-Degraef, Marie
    Leost, Francoise
    Cherel, Michel
    Gestin, Jean-Francois
    Le Bars, Didier
    Barbet, Jacques
    Faivre-Chauvet, Alain
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (01) : 154 - 157
  • [29] Radiosynthesis of 11-[18F] fluoroundecyltriphenylphosphonium (MitoF) as a potential mitochondria-specific positron emission tomography radiotracer
    Li, L.
    Brichard, L.
    Larsen, L.
    Menon, D. K.
    Smith, R. A. J.
    Murphy, M. P.
    Aigbirhio, F. I.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (14) : 717 - 721
  • [30] Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer
    Denholt, Charlotte Lund
    Binderup, Tina
    Stockhausen, Marie-Therese
    Paulsen, Hans Skovgaard
    Spang-Thomsen, Mogens
    Hansen, Paul Robert
    Gillings, Nic
    Kjaer, Andreas
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (04) : 509 - 515